1 Gebrauchsinformation: Information für Anwender LAIS Milben 1.000 UA Sublingualtabletten Chemisch modifizierte Allergenextrakt
![1 Gebrauchsinformation: Information für Anwender LAIS Milben 1.000 UA Sublingualtabletten Chemisch modifizierte Allergenextrakt 1 Gebrauchsinformation: Information für Anwender LAIS Milben 1.000 UA Sublingualtabletten Chemisch modifizierte Allergenextrakt](https://sanova.at/wp-content/uploads/2020/09/xPILLaisMilbentablets_July2020_DE_final_con-diario-pdf-724x1024.jpg.pagespeed.ic.3-RmpK5_dc.jpg)
1 Gebrauchsinformation: Information für Anwender LAIS Milben 1.000 UA Sublingualtabletten Chemisch modifizierte Allergenextrakt
![Parietaria sublingual allergoid immunotherapy with a co-seasonal treatment schedule | Allergologia et Immunopathologia Parietaria sublingual allergoid immunotherapy with a co-seasonal treatment schedule | Allergologia et Immunopathologia](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S0301054608725278:gr4.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNe5umqYt0zKZP4SYniTZ7+SgZrkCgayp3MRA1ovxa2vUxRfI/WuR9U+nfb86qvfSC337vI41dDVF3ZJqQjJZXqZ8AtfofwW6nQgXvcXpteRHik9i1m17x2po/mtHbX9siJgo4Xg02J8t5r2RJ8pmpCFzp1hYgZAtD8XDr9GXGuthBX5aQmDp3TIihWRul1xJY/5fcbbyQ/yfouh44nrv4p6M32ySxyJP5pSEMOJFPtadc+KZcLlKnLEEUShw8KCTSwFZEjUL1rppUQd4kiIgkEx)
Parietaria sublingual allergoid immunotherapy with a co-seasonal treatment schedule | Allergologia et Immunopathologia
![PDF) Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: Results of an observational open controlled parallel group study in real-life setting PDF) Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: Results of an observational open controlled parallel group study in real-life setting](https://i1.rgstatic.net/publication/7825810_Rhinitis_and_asthma_co-morbidity_in_respiratory_allergy_due_to_house_dust_mite_Results_of_an_observational_open_controlled_parallel_group_study_in_real-life_setting/links/54ef736d0cf2432ba656c808/largepreview.png)
PDF) Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: Results of an observational open controlled parallel group study in real-life setting
![Parietaria sublingual allergoid immunotherapy with a co-seasonal treatment schedule | Allergologia et Immunopathologia Parietaria sublingual allergoid immunotherapy with a co-seasonal treatment schedule | Allergologia et Immunopathologia](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S0301054608725278:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNe5umqYt0zKZP4SYniTZ7+SgZrkCgayp3MRA1ovxa2vUxRfI/WuR9U+nfb86qvfSC337vI41dDVF3ZJqQjJZXqZ8AtfofwW6nQgXvcXpteRHik9i1m17x2po/mtHbX9siJgo4Xg02J8t5r2RJ8pmpCFzp1hYgZAtD8XDr9GXGuthBX5aQmDp3TIihWRul1xJY/5fcbbyQ/yfouh44nrv4p6M32ySxyJP5pSEMOJFPtadc+KZcLlKnLEEUShw8KCTSwFZEjUL1rppUQd4kiIgkEx)